Akanda

AKAN

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$3.86

-0.04 (-1.03%)

Market Cap

$124,933

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Dec 31, 2025

How the score breaks down

Quality

Weak

Growth

Weak

Cash Flow

Weak

Stability

Data not available

Valuation

Data not available

Track this stock — start free trial

Share count rising — dilution

+11827.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 578 (2021) → 69K (2025)

Winston Score History

The full picture

Akanda Corp. is a small cannabis company focused on growing, processing, and selling medical cannabis and hemp products. It targets patients and healthcare providers in regulated medical cannabis markets, primarily in Europe and Africa. The company operates through subsidiaries with cultivation facilities in Portugal and distribution reach into several European countries.

Akanda makes money by selling medical cannabis flower, oils, and related products to licensed distributors and pharmacies. It is a very small company with a market cap near zero and deeply negative margins, meaning it currently spends far more than it earns. The biggest risk facing Akanda is its financial survival — the company has struggled to generate meaningful revenue, and its extremely negative gross and operating margins suggest it is burning through cash at a rate that raises serious questions about its ability to continue operating without raising additional funds.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-28.2% YoY

YoY Growth Rate

Revenue declining

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

0.6%ownership

Relatively low insider ownership

Cash Runway

~0 months

$503,562 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Akanda has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

-350.2%

Thin — -350.2% gross margin

Profit after running costs

Operating Margin

-1445.0%

Losing money on operations — -1445.0%

Return on the money invested

ROCE

-122.1%

Weak — -122.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-69.2%

Shrinking sales (-69.2% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-3085.6%

Burning cash (-3085.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial